GRANDE PHARMACIE BEL'AIR : revenue, balance sheet and financial ratios

GRANDE PHARMACIE BEL'AIR is a French company founded 20 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in RAMBOUILLET (78120), this company of category PME shows in 2021 a revenue of 6.2 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - GRANDE PHARMACIE BEL'AIR (SIREN 488686577)
Indicator 2023 2021 2020 2019 2018 2017 2016
Revenue N/C 6 163 646 € 5 872 587 € 6 310 192 € 6 269 053 € 5 997 609 € 6 222 304 €
Net income -404 610 € 484 682 € 172 322 € 144 308 € 33 437 € 154 003 € 220 358 €
EBITDA N/C 571 992 € 304 848 € 258 638 € 115 877 € 281 701 € 378 029 €
Net margin N/C 7.9% 2.9% 2.3% 0.5% 2.6% 3.5%

Revenue and income statement

In 2023, GRANDE PHARMACIE BEL'AIR records a net loss of 405 k€. This deficit will reduce equity on the balance sheet.

Net income (2023) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

-404 610 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 641%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 11%. Low autonomy: the company heavily depends on external financing (banks, suppliers).

Debt ratio (2023) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

640.747%

Financial autonomy (2023) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

11.434%

Asset age ratio (2023) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

72.7%

Solvency indicators evolution
GRANDE PHARMACIE BEL'AIR

Sector positioning

Debt ratio
640.75 2023
2020
2021
2023
Q1: 20.09
Med: 66.92
Q3: 169.24
Watch +23 pts over 3 years

In 2023, the debt ratio of GRANDE PHARMACIE BEL'AIR (640.75) ranks in the top 25% of the sector. This ratio measures the weight of debt relative to equity. A high ratio may indicate excessive dependence on external financing.

Financial autonomy
11.43% 2023
2020
2021
2023
Q1: 28.72%
Med: 48.51%
Q3: 68.17%
Average -25 pts over 3 years

In 2023, the financial autonomy of GRANDE PHARMACIE BEL'AIR (11.4%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.

Repayment capacity
6.87 years 2021
2020
2021
Q1: 1.06 years
Med: 3.56 years
Q3: 7.31 years
Average

In 2021, the repayment capacity of GRANDE PHARMACIE BEL'AIR (6.87) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 182.61. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2023) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

182.607

Liquidity indicators evolution
GRANDE PHARMACIE BEL'AIR

Sector positioning

Liquidity ratio
182.61 2023
2020
2021
2023
Q1: 135.25
Med: 189.78
Q3: 270.35
Average -7 pts over 3 years

In 2023, the liquidity ratio of GRANDE PHARMACIE BEL'AIR (182.61) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.

Interest coverage
7.05x 2021
2020
2021
Q1: 0.27x
Med: 2.43x
Q3: 5.92x
Excellent

In 2021, the interest coverage of GRANDE PHARMACIE BEL'AIR (7.0x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.

Operating WCR (2023) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2023) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

0 j

Supplier credit (2023) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

0 j

Inventory turnover (2023) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
GRANDE PHARMACIE BEL'AIR

Positioning of GRANDE PHARMACIE BEL'AIR in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare GRANDE PHARMACIE BEL'AIR with other companies in the same sector:

Frequently asked questions about GRANDE PHARMACIE BEL'AIR

What is the revenue of GRANDE PHARMACIE BEL'AIR ?

The revenue of GRANDE PHARMACIE BEL'AIR in 2021 is 6.2 M€.

Is GRANDE PHARMACIE BEL'AIR profitable?

GRANDE PHARMACIE BEL'AIR recorded a net loss in 2023.

Where is the headquarters of GRANDE PHARMACIE BEL'AIR ?

The headquarters of GRANDE PHARMACIE BEL'AIR is located in RAMBOUILLET (78120), in the department Yvelines.

Where to find the tax return of GRANDE PHARMACIE BEL'AIR ?

The tax return of GRANDE PHARMACIE BEL'AIR is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does GRANDE PHARMACIE BEL'AIR operate?

GRANDE PHARMACIE BEL'AIR operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.